ProfileOfResearchers

TÃTULO: Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 Trial
AUTORES: Jung Min Lee; Austin Miller; Peter G Rose; Mariam Alhilli; Christina Washington; Veena S John; Chirag A Shah; Koji Matsuo; Jean Siedel; David Scott Miller ; Elizabeth E Hopp; Andrea O’shea; John K Chan; Leslie S Bradford; Christopher B Morse; Christa I Nagel; Kerry J Rodabaugh; Elise C Kohn; Kathleen N Moore; Joyce F Liu;
PUBLICAÇÃO: 2025, FONTE: Clinical Cancer Research, VOLUME: 31, NÚMERO: 12

INDEXADO EM:

Scopus

NO MEU:

ORCID

TÃTULO: Data from Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 Trial
AUTORES: Jung-Min Lee; Austin Miller; Peter G Rose; Mariam AlHilli; Christina Washington; Veena S John; Chirag A Shah; Koji Matsuo; Jean Siedel; David Scott Miller ; Elizabeth E Hopp; Andrea O’Shea; John K Chan; Leslie S Bradford; Christopher B Morse; Christa I Nagel; Kerry J Rodabaugh; Elise C Kohn; Kathleen N Moore; Joyce F Liu;
PUBLICAÇÃO: 2025

INDEXADO EM:

CrossRef

NO MEU:

ORCID

TÃTULO: E7386 study 102: Global dose-expansion cohort of E7386 + lenvatinib (LEN) in patients (pts) with advanced endometrial cancer (aEC) that progressed on platinum-based chemotherapy (chemo) and an anti-PD-(L)1 immunotherapy (IO).
AUTORES: Jung-Yun Lee; Kosei Hasegawa; Byoung-Gie Kim; Barry S Berman; Shiro Suzuki; Bradley Corr; Mayu Yunokawa; Douglas Orr; Noboru Yamamoto; Pamela T Soliman; David Scott Miller ; Takatoshi Sahara; Lea Dutta; Jincao Wu; Jodi McKenzie; Vicky Makker;
PUBLICAÇÃO: 2025, FONTE: Journal of Clinical Oncology, VOLUME: 43, NÚMERO: 16_suppl

INDEXADO EM:

CrossRef

NO MEU:

ORCID

TÃTULO: Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma
AUTORES: Daniela E Matei; Danielle M Enserro; Marcus E Randall; David Mutch; William Small; Paul A Disilvestro; Nick M Spirtos; David M O'Malley; Guilherme H Cantuaria; David Michelin; Steven Waggoner; Mark Shahin; Saketh Guntupalli; Olivia Lara; Frederick R Ueland; David Warshal; Albert Bonebrake; Krishnansu S Tewari; Annie Tan; Matthew A Powell; Joan L Walker; Alessandro D Santin; Jong Hyeok Kim; David Scott Miller ; ...Mais
PUBLICAÇÃO: 2025, FONTE: Journal of Clinical Oncology, VOLUME: 43, NÚMERO: 9

INDEXADO EM:

Scopus

NO MEU:

ORCID

TÃTULO: Molecular Classification of Endometrial Cancers (EC) and Association with Relapse-Free Survival (RFS) and Overall Survival (OS) Outcomes: Ancillary Analysis of GOG-0258
AUTORES: Aine Clements; Danielle Enserro; Kyle C Strickland; Rebecca A Previs; Daniela E Matei; David G Mutch; Matthew A Powell; Ann H Klopp; David Scott Miller ; William Small Jr.; Paul DiSilvestro; Nick M Spirtos; Casey Cosgrove; Greg Sfakianos; Rebecca R Liu; Roberto Vargas; Mark Shahin; Bradley R Corr; Kimberly Dessources; Frederick Ueland; David Warshal; Jessica Gillen; Angeles Alvarez Secord; ...Mais
PUBLICAÇÃO: 2025

INDEXADO EM:

CrossRef

NO MEU:

ORCID

TÃTULO: Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258 Full Text
AUTORES: Clements, A; Enserro, D; Strickland, KC; Previs, R; Matei, D; Mutch, D; Powell, M; Klopp, A; David Scott Miller ; Small, W Jr; Disilvestro, P; Spirtos, N; Cosgrove, C; Sfakianos, G; Liu, JR; Vargas, R; Shahin, M; Corr, B; Dessources, K; Ueland, F; Warshal, D; Gillen, J; Secord, AA; ...Mais
PUBLICAÇÃO: 2025, FONTE: GYNECOLOGIC ONCOLOGY, VOLUME: 193

INDEXADO EM:

Scopus

WOS

Unpaywall

NO MEU:

ORCID

TÃTULO: Prospective assessment of prognostic significance of malignant peritoneal cytology in endometrial cancer: An NRG Oncology / Gynecologic Oncology Group study on GOG-210 protocol
AUTORES: Koji Matsuo; Danielle M Enserro; Jason D Wright; Lynda D Roman; Matthew A Powell; David Scott Miller ; Christa I Nagel; Premal H Thaker; Robert S Mannel; Ashley R Stuckey; Saketh R Guntupalli; Paniti Sukumvanich; Melissa A Geller; Roberto Vargas; Gottfried E Konecny; David P Warshal; Krishnansu S Tewari; Nick M Spirtos; Bhavana Pothuri; William T Creasman; David G Mutch; ...Mais
PUBLICAÇÃO: 2025, FONTE: Gynecologic Oncology, VOLUME: 201

INDEXADO EM:

Scopus

NO MEU:

ORCID

TÃTULO: Supplementary Appendix S1 from Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 Trial
AUTORES: Jung-Min Lee; Austin Miller; Peter G Rose; Mariam AlHilli; Christina Washington; Veena S John; Chirag A Shah; Koji Matsuo; Jean Siedel; David Scott Miller ; Elizabeth E Hopp; Andrea O’Shea; John K Chan; Leslie S Bradford; Christopher B Morse; Christa I Nagel; Kerry J Rodabaugh; Elise C Kohn; Kathleen N Moore; Joyce F Liu;
PUBLICAÇÃO: 2025

INDEXADO EM:

CrossRef

NO MEU:

ORCID

TÃTULO: Supplementary Figure S1 from Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 Trial
AUTORES: Jung-Min Lee; Austin Miller; Peter G Rose; Mariam AlHilli; Christina Washington; Veena S John; Chirag A Shah; Koji Matsuo; Jean Siedel; David Scott Miller ; Elizabeth E Hopp; Andrea O’Shea; John K Chan; Leslie S Bradford; Christopher B Morse; Christa I Nagel; Kerry J Rodabaugh; Elise C Kohn; Kathleen N Moore; Joyce F Liu;
PUBLICAÇÃO: 2025

INDEXADO EM:

CrossRef